Triathlon supported a global medical device client to develop a framework for product pipeline portfolio management yielding a structured analysis and prioritization of new product ideas and product development programs.
Triathlon Healthtech
Cases
Life Science
Pipeline Portfolio Management
Life Science
Medtech Market Planning
A global medical device company has grown rapidly in recent years and needed a market plan to structure future efforts. Triathlon supported the client in the assessment of the current situation and development of a strategic plan with key components in place
A global medical device company has grown rapidly in recent years and needed a market plan to structure future efforts. Triathlon supported the client in the assessment of the current situation and development of a strategic plan with key components in place
Life Science
Successful MDR implementation
A global medical device manufacturer had to adapt operations to comply with the new EU MDR. Triathlon established an enterprise-wide action plan and effective follow-up structure to drive implementation.
A global medical device manufacturer had to adapt operations to comply with the new EU MDR. Triathlon established an enterprise-wide action plan and effective follow-up structure to drive implementation.
Life Science
Digital health development & launch
A large global medical device company had set a target to rapidly launch a new digital concept to remain competitive and leverage key industry trends. Triathlon supported with managing and coordinating a cross-functional team resulting in a successful launch that doubled initial sales target.
A large global medical device company had set a target to rapidly launch a new digital concept to remain competitive and leverage key industry trends. Triathlon supported with managing and coordinating a cross-functional team resulting in a successful launch that doubled initial sales target.
Life Science
U.S. expansion plan
To manage FDA requirements and outline the best way to market, Triathlon supported a Swedish MedTech company entering the U.S. with the development of a new business model for the U.S. market. The project resulted in an FDA approval and several contracts secured with major hospitals and clinics.
To manage FDA requirements and outline the best way to market, Triathlon supported a Swedish MedTech company entering the U.S. with the development of a new business model for the U.S. market. The project resulted in an FDA approval and several contracts secured with major hospitals and clinics.
Featured Insights
Building a Culture of Innovation
Innovation is a key recipe for success, yet most organizations still struggle to generate and execute enough new ideas to the desired level of novelty. There are many aspects critical to innovation, but successful companies seem to share the common denominator of a visionary leadership and culture that facilitates innovation...
Mandatory Human Rights and Environmental Due Diligence
The long-awaited proposal for an EU Directive on mandatory human rights and environmental due diligence has finally been released, following the increasing global momentum towards socially responsible and sustainable business. A topic that in times like these is ever more relevant.
Navigating the regulatory space for MedTech AI
Artificial Intelligence (AI) holds unprecedented potential to transform how healthcare is delivered and will be vital to enable qualitative and cost-effective care in the future. However, the regulatory landscape for the intersection between healthcare and AI creates new challenges for innovators. Challenges that need to be successfully managed to launch new AI-medtech.
What is your contribution to Agenda 2030?
United Nations’ 17 Sustainability Development Goals (SDG) show the direction on how to make an impact on the world’s most urgent societal challenges. These goals aim to mobilize efforts and they call for action to organizations around the globe to use innovation and creativity to combat these challenges.
Triathlon Group’s Industrial Report 2021/22
Triathlon Group’s annual Industrial Report (Verkstadsrapporten) shows that the Western Sweden’s manufacturing industry was initially hit hard by the COVID-19 pandemic in 2020, but recovery has been rapid and forecasts for the future are positive. However, uncertainties exist on how the cost development of raw materials and transports will progress, which is indicated in this year’s report.
